Entrada Therapeutics Stock Price Patterns
| TRDA Stock | USD 11.58 0.29 2.57% |
Momentum 46
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (1.02) | EPS Estimate Current Year (3.60) | EPS Estimate Next Year (4.02) | Wall Street Target Price 18.5 | EPS Estimate Current Quarter (0.96) |
Using Entrada Therapeutics hype-based prediction, you can estimate the value of Entrada Therapeutics from the perspective of Entrada Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Entrada Therapeutics using Entrada Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Entrada using crowd psychology based on the activity and movement of Entrada Therapeutics' stock price.
Entrada Therapeutics Short Interest
A significant increase or decrease in Entrada Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Entrada. Short interest can provide insight into the potential direction of Entrada Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 7.9016 | Short Percent 0.0431 | Short Ratio 3.62 | Shares Short Prior Month 858.5 K | 50 Day MA 10.8324 |
Entrada Therapeutics Hype to Price Pattern
Investor biases related to Entrada Therapeutics' public news can be used to forecast risks associated with an investment in Entrada. The trend in average sentiment can be used to explain how an investor holding Entrada can time the market purely based on public headlines and social activities around Entrada Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Entrada Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Entrada Therapeutics.
Entrada Therapeutics Implied Volatility | 2.86 |
Entrada Therapeutics' implied volatility exposes the market's sentiment of Entrada Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Entrada Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Entrada Therapeutics stock will not fluctuate a lot when Entrada Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Entrada Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Entrada because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Entrada Therapeutics after-hype prediction price | USD 11.26 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Entrada contract
Based on the Rule 16, the options market is currently suggesting that Entrada Therapeutics will have an average daily up or down price movement of about 0.18% per day over the life of the 2026-04-17 option contract. With Entrada Therapeutics trading at USD 11.58, that is roughly USD 0.0207 . If you think that the market is fully incorporating Entrada Therapeutics' daily price movement you should consider acquiring Entrada Therapeutics options at the current volatility level of 2.86%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Entrada Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Entrada Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Entrada Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Entrada Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Entrada Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Entrada Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Entrada Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Entrada Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Entrada Therapeutics' historical news coverage. Entrada Therapeutics' after-hype downside and upside margins for the prediction period are 8.10 and 14.42, respectively. We have considered Entrada Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Entrada Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Entrada Therapeutics is based on 3 months time horizon.
Entrada Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Entrada Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Entrada Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Entrada Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.24 | 3.16 | 0.03 | 0.00 | 8 Events / Month | 2 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
11.58 | 11.26 | 0.27 |
|
Entrada Therapeutics Hype Timeline
Entrada Therapeutics is at this time traded for 11.58. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.0. Entrada is forecasted to decline in value after the next headline, with the price expected to drop to 11.26. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.27%, whereas the daily expected return is at this time at 0.24%. The volatility of related hype on Entrada Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 11.58. About 12.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Entrada Therapeutics recorded a loss per share of 2.57. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Entrada Therapeutics Basic Forecasting Models to cross-verify your projections.Entrada Therapeutics Related Hype Analysis
Having access to credible news sources related to Entrada Therapeutics' direct competition is more important than ever and may enhance your ability to predict Entrada Therapeutics' future price movements. Getting to know how Entrada Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Entrada Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KLDO | Kaleido Biosciences | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 4,998 | |
| IVBT | Innovation1 Biotech | 0.00 | 6 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XENO | Xeno Transplants | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CALA | Calithera Biosciences | 0.00 | 2 per month | 20.48 | 0.16 | 100.00 | (50.00) | 280.00 | |
| NMRD | Nemaura Medical | 0.00 | 2 per month | 0.00 | (0.14) | 0.00 | 0.00 | 50.00 | |
| SYVC | Synovics Pharmaceuticals | 0.00 | 6 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SNNAQ | Sienna Biopharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FPMI | Fluoropharma Medical | 0.00 | 9 per month | 0.00 | 0.12 | 0.00 | 0.00 | 100.00 |
Entrada Therapeutics Additional Predictive Modules
Most predictive techniques to examine Entrada price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Entrada using various technical indicators. When you analyze Entrada charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Entrada Therapeutics Predictive Indicators
The successful prediction of Entrada Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Entrada Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Entrada Therapeutics based on analysis of Entrada Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Entrada Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Entrada Therapeutics's related companies. | 2010 | 2025 | 2026 (projected) | Graham Number | 21.33 | 19.19 | 17.06 | Receivables Turnover | 21.95 | 51.55 | 31.69 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Entrada Stock analysis
When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |